Serotonin Syndrome: Diagnosis and Management
Serotonin syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the central and peripheral nervous system, characterized by a clinical triad of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities. 1
Clinical Presentation
Serotonin syndrome presents with three key categories of symptoms:
Neuromuscular Abnormalities:
- Tremor
- Hyperreflexia
- Clonus (spontaneous, inducible, or ocular)
- Muscle rigidity
- Myoclonus
Autonomic Hyperactivity:
- Tachycardia
- Hypertension (or hypotension in severe cases)
- Hyperthermia (>38°C)
- Diaphoresis
- Mydriasis
Mental Status Changes:
- Agitation
- Anxiety
- Confusion
- Delirium
- Coma (in severe cases)
Diagnostic Criteria
The Hunter criteria are the diagnostic standard for serotonin syndrome, requiring:
- Patient has taken a serotonergic agent within the past 5 weeks
- One or more of the following symptoms 1:
- Spontaneous clonus
- Inducible clonus with agitation or diaphoresis
- Ocular clonus with agitation or diaphoresis
- Tremor and hyperreflexia
- Hypertonia, temperature >38°C, and ocular or inducible clonus
Common Causative Medications
Serotonin syndrome is associated with numerous medications 1, 2:
- Antidepressants: SSRIs, SNRIs, TCAs, MAOIs
- Antimigraine drugs: Triptans
- Antiemetics: Ondansetron, metoclopramide
- Antibiotics: Linezolid
- Analgesics: Tramadol, fentanyl
- Over-the-counter medications: Dextromethorphan
- Herbal supplements: St. John's wort
- Drugs of abuse: MDMA, cocaine, LSD
Management Algorithm
Immediate discontinuation of all serotonergic agents - This is the most critical first step 1
Supportive care:
- IV fluid administration for dehydration
- External cooling for hyperthermia
- Cardiac monitoring
- Respiratory support if needed
Pharmacological management:
Monitor for complications:
- Rhabdomyolysis
- Renal failure
- Disseminated intravascular coagulation
- Seizures
Differential Diagnosis
Important conditions to distinguish from serotonin syndrome 1, 2:
- Neuroleptic Malignant Syndrome (NMS): Associated with dopamine antagonists, presents with "lead-pipe" rigidity, develops more slowly
- Anticholinergic toxicity: Presents with dry mucous membranes, urinary retention, decreased bowel sounds
- Malignant hyperthermia: Associated with anesthetic agents
- Sepsis: May have identifiable source of infection
- Decompensated hyperthyroidism: Thyroid function tests abnormal
Prognosis
- Mortality rate is approximately 11% for untreated serotonin syndrome 1
- Most mild to moderate cases resolve within 24-72 hours after discontinuation of the offending agent 5
- With prompt recognition and appropriate management, the prognosis is generally favorable 3
Prevention
- Avoid combining multiple serotonergic agents
- Be aware of drug interactions, particularly MAOIs with other serotonergic medications
- Educate patients about potential interactions with over-the-counter medications and supplements
- Maintain appropriate washout periods when switching between serotonergic medications
Common Pitfalls
- Misdiagnosis: Serotonin syndrome is frequently misdiagnosed due to its nonspecific symptoms 2
- Delayed recognition: Symptoms may be attributed to the underlying condition being treated
- Medication reconciliation errors: Failing to identify all serotonergic medications a patient is taking
- Confusing with Parkinson's disease symptoms: Tremor in serotonin syndrome may be confused with Parkinsonian tremor 4
- Overlooking mild cases: Not all three components of the clinical triad may be present simultaneously 5